InvestorsHub Logo
Followers 253
Posts 17923
Boards Moderated 0
Alias Born 01/19/2006

Re: hutschi post# 292661

Tuesday, 03/28/2017 2:52:13 AM

Tuesday, March 28, 2017 2:52:13 AM

Post# of 345818
"* Phase I/II data showing that high pre-treatment levels of interferon gamma gene signature are associated with greater benefit with durvalumab in patients with NSCLC and urothelial bladder cancer (Abstract #1773)"

Compare with :

"5. PPHM+VANDERBILT+PRECISIONMEDICINE+PROVIDENCECC: 4-3-17/1pm #CT159/25 (Session: Ph2/3 Clinical Trials in Progress), “IFN-y Analysis In Blood & Tissue as a Potential Prognostic and/or Predictive Biomarker” (abstract embargoed, Sunrise Biomarker #3) - See below." from CJG's post #290111 and 291970, above.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News